KANEKO YASUNORI 4
4 · Arcus Biosciences, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
KANEKO YASUNORI
Director
Transactions
- Award
Common Stock
2024-06-06+8,400→ 15,200 total - Award
Stock Option (Right to Buy)
2024-06-06+24,000→ 24,000 totalExercise: $15.90Exp: 2034-06-05→ Common Stock (24,000 underlying)
Holdings
- 252,524(indirect: By LLC)
Common Stock
- 146,181(indirect: By Trust)
Common Stock
- 505,050(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- [F2]The option will vest in full on the earlier of June 6, 2025 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control.